CannBioRx Life Sciences (ATNFW) has had the highest return since August 1, 2025 by a US stock, returning 3,259.4%.
| ASSET | % RETURN |
|---|---|
CannBioRx Life Sciences (ATNFW) | 3,259.38% |
Advent Technologies (ADNWW) | 372.34% |
Tharimmune (THAR) | 297.6% |
Protagenic Therapeutics (PTIXW) | 297.14% |
Equillium (EQ) | 290% |
Cognition Therapeutics (CGTX) | 258.24% |
Bolt Projects (BSLK) | 256% |
Ainos (AIMDW) | 246.23% |
BT Brands Inc Warrant (BTBDW) | 234.62% |
BioXcel Therapeutics (BTAI) | 215.06% |
Zepp Health (ZEPP) | 214.96% |
Aptorum Group Ltd Class A (APM) | 175.97% |
Advent Technologies (ADN) | 163.98% |
Atlantic International Corp Common Stock (ATLN) | 160.53% |
Telos (TLS) | 145.2% |
Gaxosai (GXAI) | 140% |
Wearable Devices (WLDSW) | 138.93% |
Real Messenger Corporation Ordinary Shares (RMSG) | 135.8% |
GCM Grosvenor (GCMGW) | 135.29% |
Jyong Biotech Ltd Ordinary Shares (MENS) | 126.44% |
Trinity Biotech (TRIB) | 122.86% |
Aeries Technology (AERTW) | 119.5% |
Precigen (PGEN) | 117.96% |
flyExclusive, Inc WT (FLYX.WT) | 114.29% |
Thayer Ventures Acquisition (TVACW) | 113.14% |
